INS and hyperuricemia: Furthermore, a meta-analysis of seven eligible trials involving 503 participants with hyperuricemia demonstrated that urate-lowering therapy led to decreases in systolic and diastolic blood pressure, fasting insulin levels, and homeostasis model assessment of insulin resistance (35).